BACKGROUND: There are limited data describing how pre-existing heart failure affects mortality following pneumonia. OBJECTIVE: To examine the association between history and severity of heart failure and mortality among patients hospitalized for pneumonia. DESIGN: Population-based cohort study in Western Denmark between 1994 and 2003. PATIENTS: 33,736 adults with a first-time hospitalization for pneumonia. Heart failure was identified and categorized based on data linked from population-based health care databases. MEASUREMENTS: We compared 30-day mortality between patients with pre-existing heart failure and other pneumonia patients, while adjusting for age, gender, comorbidity, and medication use. RESULTS: The 30-day mortality was 24.4% among heart-failure patients and 14.4% among other patients, with an adjusted 30-day mortality rate ratio (MRR) of 1.40 (95% CI: 1.29-1.51). Adjusted MRRs increased according to severity of pre-existing heart failure, as indicated by medication regimen: thiazide-based, MRR = 1.09 (95% CI: 0.79-1.50); loop-diuretics, MRR = 1.25 (95% CI: 1.10-1.43); loop-diuretics and digoxin, MRR = 1.35 (95% CI: 1.18-1.55); loop-diuretics and spironolactone, MRR = 1.72 (95% CI: 1.49-2.00). Pre-existing heart valve disease and atrial fibrillation substantially increased mortality. CONCLUSION: History and severity of heart failure are associated with a poor outcome for patients hospitalized with pneumonia.
BACKGROUND: There are limited data describing how pre-existing heart failure affects mortality following pneumonia. OBJECTIVE: To examine the association between history and severity of heart failure and mortality among patients hospitalized for pneumonia. DESIGN: Population-based cohort study in Western Denmark between 1994 and 2003. PATIENTS: 33,736 adults with a first-time hospitalization for pneumonia. Heart failure was identified and categorized based on data linked from population-based health care databases. MEASUREMENTS: We compared 30-day mortality between patients with pre-existing heart failure and other pneumoniapatients, while adjusting for age, gender, comorbidity, and medication use. RESULTS: The 30-day mortality was 24.4% among heart-failurepatients and 14.4% among other patients, with an adjusted 30-day mortality rate ratio (MRR) of 1.40 (95% CI: 1.29-1.51). Adjusted MRRs increased according to severity of pre-existing heart failure, as indicated by medication regimen: thiazide-based, MRR = 1.09 (95% CI: 0.79-1.50); loop-diuretics, MRR = 1.25 (95% CI: 1.10-1.43); loop-diuretics and digoxin, MRR = 1.35 (95% CI: 1.18-1.55); loop-diuretics and spironolactone, MRR = 1.72 (95% CI: 1.49-2.00). Pre-existing heart valve disease and atrial fibrillation substantially increased mortality. CONCLUSION: History and severity of heart failure are associated with a poor outcome for patients hospitalized with pneumonia.
Authors: M Kalin; A Ortqvist; M Almela; E Aufwerber; R Dwyer; B Henriques; C Jorup; I Julander; T J Marrie; M A Mufson; R Riquelme; A Thalme; A Torres; M A Woodhead Journal: J Infect Dis Date: 2000-08-17 Impact factor: 5.226
Authors: Eric M Mortensen; Christopher M Coley; Daniel E Singer; Thomas J Marrie; D Scott Obrosky; Wishwa N Kapoor; Michael J Fine Journal: Arch Intern Med Date: 2002-05-13
Authors: R W Thomsen; A Riis; M Nørgaard; J Jacobsen; S Christensen; C J McDonald; H T Sørensen Journal: J Intern Med Date: 2006-04 Impact factor: 8.989
Authors: Vladimir Kaplan; Derek C Angus; Martin F Griffin; Gilles Clermont; R Scott Watson; Walter T Linde-Zwirble Journal: Am J Respir Crit Care Med Date: 2002-03-15 Impact factor: 21.405
Authors: Reimar W Thomsen; Heidi H Hundborg; Hans-Henrik Lervang; Søren P Johnsen; Henrik T Sørensen; Henrik C Schønheyder Journal: Diabetes Care Date: 2004-01 Impact factor: 19.112
Authors: Lutz P Breitling; Kai-Uwe Saum; Ben Schöttker; Bernd Holleczek; Felix J Herth; Hermann Brenner Journal: Dtsch Arztebl Int Date: 2016-09-16 Impact factor: 5.594
Authors: Gabriel Wardi; Ian Joel; Julian Villar; Michael Lava; Eric Gross; Vaishal Tolia; Raghu R Seethala; Robert L Owens; Rebecca E Sell; Sydney B Montesi; Farbod N Rahaghi; Somnath Bose; Ashish Rai; Elizabeth K Stevenson; Jakob McSparron; Vaishal Tolia; Jeremy R Beitler Journal: J Intensive Care Med Date: 2019-08-25 Impact factor: 2.889
Authors: Albert Wu; Chester Good; John R Downs; Michael J Fine; Mary Jo V Pugh; Antonio Anzueto; Eric M Mortensen Journal: PLoS One Date: 2014-01-28 Impact factor: 3.240
Authors: Guowei Li; Deborah J Cook; Lehana Thabane; Jan O Friedrich; Tim M Crozier; John Muscedere; John Granton; Sangeeta Mehta; Steven C Reynolds; Renato D Lopes; Francois Lauzier; Andreas P Freitag; Mitchell A H Levine Journal: Respir Res Date: 2016-07-11